K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.
about
Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe.Issues and prospects of microRNA-based biomarkers in blood and other body fluidsColorectal Cancer Biomarkers: Where Are We Now?Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour.Fetal RhD genotyping from maternal plasma.Quantitative PCR.Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling.Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.Biomarkers in disease and health.Restriction enzymes in the analysis of genetic alterations responsible for cancer progression.Diagnostic potential of circulating nucleic acids for oncology.Detection of Y STR markers of male fetal dna in maternal circulation.Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells.A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus.Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer.Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?Circulating tumor DNA: a resuscitative gold mine?Luteal phase serum cell-free DNA as a marker of failed pregnancy after assisted reproductive technologyCirculating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patientsA critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probesAberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients.Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumoursDifferential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNAMS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistanceCirculating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma.Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.Molecular staging of colorectal cancer: new paradigm or waste of time?
P2860
Q25257416-5525570D-EE6B-411E-BAC7-083903C47829Q26991755-1D3A70CA-2BF0-4058-BFDC-190A3AF3EF02Q27003134-D2D29007-9C81-491F-965A-F09D5EF091ADQ33331704-A186E26F-1E5D-495A-B754-37912CCAA6E8Q33608810-CB04B979-FE3C-43C8-9354-68337F4A6383Q33780684-FE77B10F-7B1B-4AA2-AA6C-BF70130F2C95Q34093064-692ACABC-FB16-4AF9-8046-F5B43612E1D9Q34139666-84488856-2796-49D3-9C0B-1DDA64A19ADEQ34162584-9922008E-1131-4791-927B-77231F3EA216Q34267943-EA0B1428-8F3C-491D-A141-5765BFF479EFQ34345140-D4DB927D-52CE-44EF-8F5B-3621204D716FQ34535999-E6F9A571-A2AF-4E13-B389-61E5723C71B9Q35183642-4A655010-1B1C-4F05-805E-049C59B24FBFQ35199886-7906EBDE-9B58-4270-8AAA-37C2F3200CBCQ35594529-646A99FF-9612-4961-8CFC-E768F33CBEC1Q35595377-BBC63841-BAD8-4301-8B0E-9D797CB128D4Q35763885-1D67D4E1-BF40-4C28-B1B5-9EF3C51EAFF8Q35878266-AE4626F5-DB4C-4BF0-B8C4-4DE11908F6EEQ35964856-BF3C99FF-AB75-4220-B153-E1EE06D00D36Q36178628-DF560A55-BEFB-4726-8D2A-68CED9879BF1Q36186908-8177FAD1-FEF4-428D-A37D-8F93BB22E615Q36204919-CDD7F36B-10E4-46CD-96BD-D2619CB6070DQ36270673-F0AA6307-EB14-4CAF-86EA-C42A222DD40CQ36393312-5B885E22-B90C-42C6-A8A8-E4346FE4AF93Q36458751-5437D2AD-92F5-4817-900A-F59B3803A813Q36616092-8200F57A-EB49-4FDF-A8C9-3CD932F5E8C4Q36618056-B6D4AA73-401A-48DF-A0B8-5BE49B386985Q36641468-CE7DC810-E03C-4908-87B1-1956B65C26FCQ36646098-DB8649A9-68B3-4305-AF83-1CF85E08B5C6Q36986986-B901276B-CE7C-4C2F-BE89-1E180653D7C1Q38038406-697C8D1F-E6B2-4DE0-829F-8A8752E75C39Q38249332-D95C1952-7215-43C4-87EF-15B2728816BEQ38664513-F3C0E73D-8775-4608-AAA6-35D808F2FDA3Q38993983-BEF75ACC-F5A9-4640-A702-EFA68FEE52D9Q39600460-38A672BC-8D46-42D1-A8DB-9D77E3F5B311Q39774957-D0A6A593-A65C-4B98-A412-85A98E4D8910Q40363878-38171B04-C026-4BFE-AB9C-7311117812E4Q43905055-E6C840A6-ED33-4DAA-A8B3-C5CB2DCB3753Q46968191-E5022F61-6FB6-4895-BC3C-805BE62E9A26Q48690676-F930D1F2-376E-4370-A557-A213F5CBC9F9
P2860
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
K-ras mutations are found in D ...... tients with colorectal cancer.
@en
type
label
K-ras mutations are found in D ...... tients with colorectal cancer.
@en
prefLabel
K-ras mutations are found in D ...... tients with colorectal cancer.
@en
P2093
P1433
P1476
K-ras mutations are found in D ...... tients with colorectal cancer.
@en
P2093
Farthing MJ
Lederrey C
Mulcahy HE
Vasioukhin V
P304
P356
10.1016/S0016-5085(97)70121-5
P407
P577
1997-04-01T00:00:00Z